Sleep Duration and Cardiovascular Health

Abroad (travel likely)Recruiting

Conditions

Sleep · Cardiovascular Risk Factor

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Oregon Health and Science University, Portland, Oregon, United States
Contact: Study coordinator (Saurabh S Thosar, PhD) · clinphys@ohsu.edu · 503-494-2064
Contact: Principal Investigator (Saurabh S Thosar, PhD)

Study leads

Saurabh S Thosar, PhD
Principal Investigator
Oregon Health and Science University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Obesity · Overweight · Obstructive Sleep Apnoea

Abroad (travel likely)RecruitingPHASE3

Gilbert, United States · Bradenton, United States

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy

Obstructive Sleep Apnea

Abroad (travel likely)RecruitingPHASE3

Northridge, United States · Rolling Hills Estates, United States

Early Dental Risk Screening for Pediatric Sleep-Disordered Breathing

Early Risk Screening for Sleep Disordered Breathing in a Dental Setting · Sleep Disordered Breathing (SDB) · Obstructive Sleep Apnea (OSA)

Abroad (travel likely)Recruiting

Chapel Hill, United States

Sleep Behaviors in Pregnancy

Sleep · Pregnancy Complications

Abroad (travel likely)Recruiting

Ann Arbor, United States